BCR and acute lymphoblastic leukemia: Similarly, Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL), characterized by chromosomal translocations between chromosomes 9 and 22, resulting in the expression of an oncogenic BCR-ABL1 fusion protein, relies on CXCR4 for the survival of BCR-ABL1-transformed mouse preB cells.